insulins	are	hormone
insulins	regulate	glucose
insulins	secreted by	pancreas
insulins	bind to	insulin receptor
insulin receptor	activates	PI3K pathway
PI3K pathway	promotes	glucose uptake
glucose uptake	reduces	blood glucose
insulins	treat	type 1 diabetes
insulins	treat	type 2 diabetes
type 1 diabetes	requires	insulin therapy
type 2 diabetes	may require	insulin therapy
insulins	have	onset time
onset time	varies by	formulation
formulation	can be	rapid‑acting
formulation	can be	short‑acting
formulation	can be	intermediate‑acting
formulation	can be	long‑acting
rapid‑acting	starts	5–15 min
short‑acting	starts	30–60 min
intermediate‑acting	starts	1–2 h
long‑acting	starts	2–4 h
insulins	have	duration
duration	ranges from	5–24 h
insulins	can cause	hypoglycemia
hypoglycemia	predicts	mortality risk
hypoglycemia	predicts	readmission risk
insulins	can cause	weight gain
weight gain	predicts	cardiovascular risk
insulins	can cause	edema
edema	predicts	heart failure
insulins	can cause	skin reactions
skin reactions	predict	adherence issues
insulins	are	prescription drug
prescription drug	requires	monitoring
monitoring	includes	HbA1c
HbA1c	predicts	long‑term complications
HbA1c	predicts	mortality
insulins	are	injectable
injectable	can be	pen device
injectable	can be	vial
pen device	improves	adherence
adherence	predicts	glycemic control
glycemic control	predicts	microvascular complications
glycemic control	predicts	macrovascular complications
insulins	are	analogues
analogues	designed to	mimic natural insulin
analogues	reduce	post‑prandial spikes
post‑prandial spikes	predict	cardiovascular events
insulins	have	side effect profile
side effect profile	influences	drug choice
drug choice	influences	cost
cost	influences	adherence
adherence	influences	hospitalization
hospitalization	predicts	mortality
insulins	interact with	oral hypoglycemics
interaction	can cause	hypoglycemia
insulins	interact with	steroids
steroids	increase	insulin resistance
insulin resistance	predicts	insulin dose requirement
dose requirement	predicts	cost burden
dose requirement	predicts	weight gain
insulins	are	brand name
brand name	can be	human insulin
brand name	can be	analog insulin
human insulin	has	neutral pH
analog insulin	has	modified amino acids
modified amino acids	reduce	aggregation
aggregation	reduces	injection pain
injection pain	reduces	adherence
adherence	reduces	readmission
readmission	predicts	mortality
insulins	are	regulated by	FDA
FDA regulation	ensures	safety
safety	predicts	adverse event rate
adverse event rate	predicts	mortality
insulins	are	stored	refrigerated
refrigerated	prevents	degradation
degradation	leads to	loss of potency
loss of potency	leads to	hyperglycemia
hyperglycemia	predicts	complications
complications	predict	mortality
insulins	are	available	in	multiple countries
availability	predicts	access
access	predicts	adherence
adherence	predicts	glycemic control
glycemic control	predicts	complications
complications	predict	mortality
insulins	are	subject to	patent
patent	affects	price
price	affects	adherence
adherence	affects	readmission
readmission	affects	mortality
insulins	are	used in	basal‑bolus regimen
basal‑bolus	improves	glucose variability
glucose variability	predicts	hypoglycemia
hypoglycemia	predicts	mortality
insulins	are	used in	premixed regimen
premixed	simplifies	dosing
simplifies	improves	adherence
adherence	improves	outcomes
